Coltac Therapeutics
Biotech
Services
Brand Strategy · Visual Identity · Website Design · Webflow Development
Biotech branding for a molecular glue discovery platform targeting oncology and beyond.
Coltac Therapeutics is developing the next generation of molecular glues for targeted protein degradation, using a proprietary bacteria-based screening platform that is faster, more specific, and significantly less costly than conventional approaches. Backed by aMoon Fund, Israel Biotech Fund, and Ramot at Tel Aviv University, the company needed a brand and website that could communicate the depth of its science to partners, pharma collaborators, and investors worldwide. The Bract Agency handled everything from identity to launch.
A biotech brand built to open doors with pharma partners and investors globally
→
Outcome
Full brand system and Webflow website delivered for a preclinical biotech company with institutional backing, built to translate highly complex science into a compelling and credible presence for the global drug discovery market.
Program
Launch
Timeline
8 weeks
Stage
Series A
Groundbreaking science, invisible to the people who needed to find it
The problem
Biotech companies live and die by their ability to communicate complex science to non-scientists. Molecular glues are one of the most promising drug modalities in the field, but also one of the hardest to explain. Coltac had a genuinely differentiated platform and serious institutional backing, but without a brand, the technology was invisible to the pharma partners and investors who needed to find it. The website and identity needed to close that gap, fast.
Everything we've done.
Our services
Brand Strategy
01
Molecular glue therapeutics is one of the most technically complex and most closely watched modalities in drug discovery right now. Coltac's positioning needed to reflect both the ambition of the science and the rigor of the platform. We anchored the brand around a single truth: Coltac does not just discover molecular glues faster. It discovers them differently, with a platform built to solve the signal-to-noise problem that slows everyone else down.
Visual Identity
02
A visual system built for a company where the science is the story. The identity needed to feel bold enough to stand out at BIO and JPMorgan, precise enough to communicate scientific rigor, and modern enough to signal that Coltac is building for the future of the field. No generic lab aesthetics. A brand that looks as sharp as the platform behind it.
Website Design
03
A website designed to do what Coltac's team does in every pitch: take deeply technical science and make it immediately legible to a sophisticated audience. The design prioritizes clarity and confidence, giving pharma partners and biotech investors exactly the information they need to understand why the BOND+ platform matters, in the time it takes to scroll a homepage.
Webflow Development
04
Built and launched on Webflow for full in-house control. The site is fast, accessible, and designed to be updated as the pipeline evolves, without relying on an external developer every time a program advances or a new collaboration is announced.
A brand as precise as the science behind it
Results
Coltac now has a brand presence that matches the ambition of its platform. The identity and website give the team a credible, professional face for every high-stakes interaction: investor meetings, pharma partnership conversations, and international conferences. In a field where first impressions matter and scientific credibility is evaluated before the first meeting, the brand does the heavy lifting.
We needed investors and pharma partners to understand what we built before we had a chance to explain it. The Bract made that possible.
Coltac Therapeutics
